# Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage

> **NCT00487461** · NA · TERMINATED · sponsor: **University of Illinois at Chicago** · enrollment: 25 (actual)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage
- Cerebral Vasospasm

## Interventions

- **DRUG:** Simvastatin 40 mg
- **DRUG:** Placebo
- **DRUG:** Simvastatin 80 mg

## Key facts

- **NCT ID:** NCT00487461
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2009-02
- **Final completion:** 2009-06
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Study PI left the institution and study was stopped at that time.
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487461, "Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00487461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*